טוען...
Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
Treatment of patients with chronic kidney disease (CKD) and chronic hepatitis C (CHC) differs from that used in the general CHC population mostly when glomerular filtration rate (GFR) is below 30 mL/min, as sofosbuvir, the backbone of several current regimens, is officially contraindicated. Given th...
שמור ב:
| הוצא לאור ב: | World J Hepatol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5295158/ https://ncbi.nlm.nih.gov/pubmed/28217256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v9.i4.180 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|